Sök artiklar i SveMed+

Observera: SveMed+ upphör att uppdateras!



Dilateret kardiomyopati som bivirkning af infliximabbehandling
Engelsk titel: Dilated cardiomyopathy as a side effect of treatment with infliximab Läs online Författare: Leetmaa TH ; Markenvard JD Språk: Dan Antal referenser: 5 Dokumenttyp: Fallbeskrivning UI-nummer: 05091704

Tidskrift

Ugeskrift for Laeger 2005;167(39)3699-701 ISSN 0041-5782 E-ISSN 1603-6824 KIBs bestånd av denna tidskrift Denna tidskrift är expertgranskad (Peer-Reviewed)

Sammanfattning

We report a case of heart failure after infusion of Remicade (infliximab) in a patient without heart insufficiency. The patient, a 25-year-old woman with inflammatory bowel disease, developed new-onset heart failure after receiving TNF antagonist therapy. After the treatment was discontinued and heart failure therapy was started, the patient improved significantly. The U.S. Food and Drug Administration has published 47 case reports of heart failure after therapy with a tumor necrosis factor antagonist, where 38 patients developed new-onset heart failure and 9 patients experienced heart failure exacerbation.There are no published reports of heart failure after TNF antagonist therapy in the Danish literature.